Tag: Pharmaceutical Costs

Medicare Part D Spending Hits Record High Amid Industry Shifts

Medicare Part D is facing record-high payouts driven by rising drug costs and utilization, challenging health insurers and coinciding with shifts in industry conference participation.

Medicare Part D Coverage Tightens as GLP-1 Drug Costs and Prior Authorizations Rise

Medicare Part D sees near-universal prior authorization and rising out-of-pocket costs for GLP-1 drugs in 2025, reflecting insurer adjustments to new cost and regulatory pressures.